<DOC>
	<DOCNO>NCT00102739</DOCNO>
	<brief_summary>This study double-blind , randomize , placebo-controlled , parallel group , repeat-dose , study conduct two part ( Part A Part B ) examine 30 , 50 , 75 mg dose SB-497115-GR treatment patient ITP fail prior therapy . The study design determine proportion patient platelet count =50,000/µL 42 day . In Part B , 99 newly-recruited subject randomize one two dosing arm 2:1 ratio active : placebo . During 6 week study period , subject start placebo active drug ( 50 mg ) may dose increase 75 mg base upon platelet count day 22 .</brief_summary>
	<brief_title>SB-497115 ( Oral Thrombopoietin Receptor Agonist ) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura ( ITP )</brief_title>
	<detailed_description>A double-blind , randomize , placebo-controlled , parallel group study investigate efficacy , safety , tolerability , pharmacokinetics , pharmacodynamics SB-497119-GR , thrombopoietin receptor agonist , administer 30 , 50 , 75 mg oral tablet once-daily 6 week adult male female subject refractory , chronic immune thrombocytopenia purpura</detailed_description>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<criteria>Inclusion criterion : Patients chronic low platelet count ( le 30,000/µL ) 6 month fail least one treatment chronic low platelet count . Patients receive chronic maintenance steroid therapy must receive stable dose least 1 month . Normal PT PTT . Exclusion criterion : History clot disorder . Females pregnant receive hormone replacement therapy systemic contraceptive . History alcohol/drug abuse dependence within 1 year . Use aspirin , aspirincontaining compound , salicylate , antacid , rosuvastatin , pravastatin , nonsteroidal antiinflammatory drug study within 3 week prior start study . History HIV infection active infection Hepatitis B C .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>thrombopoietin</keyword>
	<keyword>immune thrombocytopenic purpura</keyword>
	<keyword>platelet</keyword>
	<keyword>chronic thrombocytopenia</keyword>
</DOC>